This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Haoyuan Medchemexpress Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Qi Wei Zhu
Introduction
Qi Wei Zhu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of camptothecin derivatives. His work is characterized by innovative methods that enhance the efficiency and cost-effectiveness of pharmaceutical production.
Latest Patents
Qi Wei Zhu holds a patent for an "Intermediate for synthesizing camptothecin derivative, preparation method therefor, and use thereof." This patent describes an intermediate compound A that can be synthesized from 3-fluoro-4-methylaniline through a series of reactions including acylation, bromination, and cross-coupling. The intermediate A is crucial for preparing intermediate B, which is further used to produce exatecan mesylate. The process is notable for its low-cost starting materials, moderate reaction conditions, and high yield, making it suitable for industrial production.
Career Highlights
Qi Wei Zhu is currently employed at Shanghai Haoyuan Medchemexpress Co., Ltd. His work at this company has allowed him to focus on the development of innovative chemical processes that have practical applications in the pharmaceutical industry. His expertise in synthetic methods has positioned him as a valuable asset in his field.
Collaborations
Qi Wei Zhu collaborates with talented colleagues such as Hong Wei Zhang and Qiang Gao. Their combined efforts contribute to advancing research and development in medicinal chemistry.
Conclusion
Qi Wei Zhu's contributions to the field of medicinal chemistry, particularly through his innovative patent, demonstrate his commitment to enhancing pharmaceutical production methods. His work continues to impact the industry positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile